Helicid

Helicid is a pharmaceutical product that contains the proton pump inhibitor omeprazole as its active ingredient. It is supplied in oral dosage form and is marketed in the European Union. Helicid is used to manage conditions associated with excess gastric acid production, offering a pharmacological approach to reduce acid secretion in the stomach.

Helicid is indicated for several acid‑related gastrointestinal conditions where reduction of gastric acidity is desired.

- Treatment of gastroesophageal reflux disease (GERD) and associated heartburn. - Healing and maintenance therapy for peptic ulcer disease. - Management of erosive esophagitis. - Part of combination regimens for Helicobacter pylori eradication. - Prevention of ulcer recurrence in patients at risk.

Adverse reactions to Helicid can vary in frequency and severity. Patients should be aware of both common and less frequent but serious events.

Common: - Headache - Diarrhea or loose stools - Nausea or abdominal discomfort - Flatulence - Constipation - Dry mouth

Serious: - Severe allergic reactions (rash, itching, swelling) - Clostridioides difficile‑associated diarrhea - Low magnesium levels (hypomagnesemia) - Liver enzyme elevations - Bone fractures with long‑term use

Before starting Helicid, certain health considerations should be reviewed to ensure safe use.

- Assess for known hypersensitivity to omeprazole or other proton pump inhibitors. - Use caution in patients with severe liver disease; dose adjustment may be required. - Evaluate the need for long‑term therapy, especially in elderly patients at risk for fractures. - Monitor magnesium levels during prolonged treatment. - Discuss pregnancy and breastfeeding status with a healthcare professional. - Review concomitant use of medications that may affect gastric pH.

Helicid can affect the absorption or metabolism of other medicines; some combinations should be avoided while others require careful monitoring.

Avoid: - Antifungal agents such as ketoconazole and itraconazole (reduced absorption). - HIV protease inhibitors (e.g., atazanavir, nelfinavir) that need acidic environment. - Certain antiplatelet drugs like clopidogrel (potential reduced effectiveness).

Use with caution: - Warfarin (possible increase in INR). - Methotrexate (higher serum concentrations). - Digoxin (altered absorption). - Diazepam and other benzodiazepines (changed plasma levels).